Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.45 |
| ▸ | FNTB | P49356 | 4/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15932787 | 0.96 | FNTA (0.39) | FNTAFNTBTRPV1KMT2AAPP | |
| SCHEMBL13860827 | 0.86 | APP (0.47) | FNTAFNTBTRPV1KMT2AAPP | |
| SCHEMBL13860828 | 0.86 | APP (0.47) | FNTAFNTBTRPV1KMT2AAPP | |
| SCHEMBL15932785 | 0.82 | FNTA (0.39) | FNTAFNTBTRPV1KMT2AALDH1A1 | |
| SCHEMBL15932786 | 0.82 | APP (0.42) | FNTAFNTBKMT2AAPPALDH1A1 | |
| SCHEMBL15932790 | 0.80 | MEN1 (0.40) | FNTAFNTBTRPV1KMT2AAPP | |
| SCHEMBL15293647 | 0.79 | APP (0.43) | FNTAFNTBTRPV1KMT2AAPP | |
| SCHEMBL10815023 | 0.78 | TRPV1 (0.42) | FNTAFNTBTRPV1ALDH1A1ALOX15 | |
| SCHEMBL10815018 | 0.78 | TRPV1 (0.42) | FNTAFNTBTRPV1ALDH1A1ALOX15 | |
| SCHEMBL10811717 | 0.78 | TRPV1 (0.42) | FNTAFNTBTRPV1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10618718-B2 | Oxygen scavengers | APG Polytech, LLC (US) | 2020-04-14 | — | — | US | disclosed |
| US-20190233195-A1 | OXYGEN SCAVENGERS | APG Polytech, LLC (US) | 2019-08-01 | — | — | US | disclosed |
| US-10207853-B2 | Oxygen scavengers | APG Polytech, LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-20140220281-A1 | OXYGEN SCAVENGERS | M&G USA CORPORATION (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140220281-A1 | OXYGEN SCAVENGERS | M&G USA CORPORATION (US) | 2014-08-07 | — | — | US | disclosed |
| WO-2013028290-A1 | OXYGEN SCAVENGERS | Amyris, Inc. (US) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013028289-A1 | OXYGEN SCAVENGERS | Amyris, Inc. (US) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10207853-B2 | Oxygen scavengers | LPO, GPX4, GPX1 | FNTA 4513/4885FNTB 4387/4885TRPV1 1196/4885 |
| US-20190233195-A1 | OXYGEN SCAVENGERS | LPO, GPX4, GPX1 | FNTA 4513/4885FNTB 4387/4885TRPV1 1196/4885 |
| US-10618718-B2 | Oxygen scavengers | LPO, GPX4, GPX1 | FNTA 4513/4885FNTB 4387/4885TRPV1 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.